nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—TOP2A—hematologic cancer	0.248	0.779	CbGaD
Sparfloxacin—TOP2A—Idarubicin—hematologic cancer	0.0789	0.171	CbGbCtD
Sparfloxacin—ABCB1—hematologic cancer	0.0706	0.221	CbGaD
Sparfloxacin—TOP2A—Daunorubicin—hematologic cancer	0.0558	0.121	CbGbCtD
Sparfloxacin—TOP2A—Teniposide—hematologic cancer	0.0485	0.105	CbGbCtD
Sparfloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0339	0.0736	CbGbCtD
Sparfloxacin—TOP2A—Epirubicin—hematologic cancer	0.0274	0.0596	CbGbCtD
Sparfloxacin—ABCC2—Daunorubicin—hematologic cancer	0.0229	0.0497	CbGbCtD
Sparfloxacin—TOP2A—Etoposide—hematologic cancer	0.0214	0.0464	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—hematologic cancer	0.0146	0.0317	CbGbCtD
Sparfloxacin—ABCB1—Lenalidomide—hematologic cancer	0.0127	0.0276	CbGbCtD
Sparfloxacin—ABCC2—Irinotecan—hematologic cancer	0.011	0.0238	CbGbCtD
Sparfloxacin—ABCC2—Vinblastine—hematologic cancer	0.00974	0.0211	CbGbCtD
Sparfloxacin—ABCC2—Vincristine—hematologic cancer	0.00957	0.0208	CbGbCtD
Sparfloxacin—ABCC2—Cisplatin—hematologic cancer	0.00893	0.0194	CbGbCtD
Sparfloxacin—ABCC2—Etoposide—hematologic cancer	0.00877	0.019	CbGbCtD
Sparfloxacin—ABCB1—Daunorubicin—hematologic cancer	0.00746	0.0162	CbGbCtD
Sparfloxacin—ABCB1—Alitretinoin—hematologic cancer	0.00731	0.0159	CbGbCtD
Sparfloxacin—ABCC2—Dexamethasone—hematologic cancer	0.00721	0.0157	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—hematologic cancer	0.00598	0.013	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—hematologic cancer	0.0058	0.0126	CbGbCtD
Sparfloxacin—ABCB1—Imatinib—hematologic cancer	0.00572	0.0124	CbGbCtD
Sparfloxacin—ABCB1—Nilotinib—hematologic cancer	0.00519	0.0113	CbGbCtD
Sparfloxacin—ABCB1—Vinorelbine—hematologic cancer	0.00515	0.0112	CbGbCtD
Sparfloxacin—ABCB1—Dasatinib—hematologic cancer	0.00459	0.00997	CbGbCtD
Sparfloxacin—ABCB1—Mitoxantrone—hematologic cancer	0.00454	0.00985	CbGbCtD
Sparfloxacin—ABCB1—Betamethasone—hematologic cancer	0.00404	0.00878	CbGbCtD
Sparfloxacin—ABCB1—Gemcitabine—hematologic cancer	0.00401	0.0087	CbGbCtD
Sparfloxacin—ABCB1—Prednisolone—hematologic cancer	0.00399	0.00866	CbGbCtD
Sparfloxacin—ABCB1—Prednisone—hematologic cancer	0.00377	0.00818	CbGbCtD
Sparfloxacin—ABCB1—Irinotecan—hematologic cancer	0.00357	0.00775	CbGbCtD
Sparfloxacin—ABCB1—Vinblastine—hematologic cancer	0.00317	0.00689	CbGbCtD
Sparfloxacin—ABCB1—Vincristine—hematologic cancer	0.00312	0.00678	CbGbCtD
Sparfloxacin—ABCB1—Cisplatin—hematologic cancer	0.00291	0.00632	CbGbCtD
Sparfloxacin—ABCB1—Etoposide—hematologic cancer	0.00286	0.00621	CbGbCtD
Sparfloxacin—ABCB1—Dexamethasone—hematologic cancer	0.00235	0.00511	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—hematologic cancer	0.00195	0.00424	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—hematologic cancer	0.00189	0.0041	CbGbCtD
Sparfloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.000719	0.297	CrCbGaD
Sparfloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.000372	0.154	CrCbGaD
Sparfloxacin—Levofloxacin—TOP2A—hematologic cancer	0.000318	0.131	CrCbGaD
Sparfloxacin—Ofloxacin—TOP2A—hematologic cancer	0.000318	0.131	CrCbGaD
Sparfloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000307	0.127	CrCbGaD
Sparfloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000246	0.0778	CbGdCrCtD
Sparfloxacin—Gatifloxacin—ALB—hematologic cancer	0.000206	0.0853	CrCbGaD
Sparfloxacin—TOP2A—blood—hematologic cancer	0.000141	0.107	CbGeAlD
Sparfloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000137	0.0432	CbGdCrCtD
Sparfloxacin—TOP2A—bone marrow—hematologic cancer	0.000136	0.103	CbGeAlD
Sparfloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000136	0.0429	CbGdCrCtD
Sparfloxacin—TOP2A—lung—hematologic cancer	0.000124	0.0934	CbGeAlD
Sparfloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000122	0.0386	CbGdCrCtD
Sparfloxacin—TOP2A—testis—hematologic cancer	0.000117	0.0882	CbGeAlD
Sparfloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	0.000104	0.0327	CbGdCrCtD
Sparfloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	9.77e-05	0.0308	CbGdCrCtD
Sparfloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	9.77e-05	0.0308	CbGdCrCtD
Sparfloxacin—ABCC2—blood—hematologic cancer	9.64e-05	0.0729	CbGeAlD
Sparfloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	9.42e-05	0.0297	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	9.23e-05	0.0291	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	9.23e-05	0.0291	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	9.23e-05	0.0291	CbGdCrCtD
Sparfloxacin—Levofloxacin—ABCB1—hematologic cancer	9.04e-05	0.0374	CrCbGaD
Sparfloxacin—Ciprofloxacin—ABCB1—hematologic cancer	8.73e-05	0.0361	CrCbGaD
Sparfloxacin—TOP2A—lymph node—hematologic cancer	8.46e-05	0.0639	CbGeAlD
Sparfloxacin—ABCC2—testis—hematologic cancer	7.97e-05	0.0603	CbGeAlD
Sparfloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	7.85e-05	0.0248	CbGdCrCtD
Sparfloxacin—SLC22A5—blood—hematologic cancer	7.47e-05	0.0564	CbGeAlD
Sparfloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	7.13e-05	0.0225	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	7e-05	0.0221	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	7e-05	0.0221	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	7e-05	0.0221	CbGdCrCtD
Sparfloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	6.59e-05	0.0208	CbGdCrCtD
Sparfloxacin—SLC22A5—lung—hematologic cancer	6.55e-05	0.0495	CbGeAlD
Sparfloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	6.36e-05	0.0201	CbGdCrCtD
Sparfloxacin—SLC22A5—testis—hematologic cancer	6.18e-05	0.0467	CbGeAlD
Sparfloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	6.17e-05	0.0195	CbGdCrCtD
Sparfloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	6.17e-05	0.0195	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	6.16e-05	0.0194	CbGdCrCtD
Sparfloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	6.16e-05	0.0194	CbGdCrCtD
Sparfloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	5.98e-05	0.0189	CbGdCrCtD
Sparfloxacin—ABCC2—lymph node—hematologic cancer	5.78e-05	0.0437	CbGeAlD
Sparfloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	5.67e-05	0.0179	CbGdCrCtD
Sparfloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	5.52e-05	0.0174	CbGdCrCtD
Sparfloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	5.3e-05	0.0167	CbGdCrCtD
Sparfloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	5.27e-05	0.0166	CbGdCrCtD
Sparfloxacin—ABCB1—hematopoietic system—hematologic cancer	5.23e-05	0.0395	CbGeAlD
Sparfloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	5e-05	0.0158	CbGdCrCtD
Sparfloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	4.7e-05	0.0148	CbGdCrCtD
Sparfloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	4.66e-05	0.0147	CbGdCrCtD
Sparfloxacin—SLC22A5—lymph node—hematologic cancer	4.48e-05	0.0338	CbGeAlD
Sparfloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	4.31e-05	0.0136	CbGdCrCtD
Sparfloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	4.24e-05	0.0134	CbGdCrCtD
Sparfloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	4.07e-05	0.0129	CbGdCrCtD
Sparfloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	4.02e-05	0.0127	CbGdCrCtD
Sparfloxacin—ABCB1—gonad—hematologic cancer	3.98e-05	0.0301	CbGeAlD
Sparfloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	3.97e-05	0.0125	CbGdCrCtD
Sparfloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	3.77e-05	0.0119	CbGdCrCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	3.77e-05	0.00102	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—CREB1—hematologic cancer	3.77e-05	0.00102	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—hematologic cancer	3.73e-05	0.00101	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MLH1—hematologic cancer	3.73e-05	0.00101	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL10—hematologic cancer	3.7e-05	0.001	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	3.7e-05	0.001	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.69e-05	0.000998	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—hematologic cancer	3.68e-05	0.000994	CbGpPWpGaD
Sparfloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	3.67e-05	0.0116	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.65e-05	0.000986	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	3.61e-05	0.000976	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL4—hematologic cancer	3.6e-05	0.000974	CbGpPWpGaD
Sparfloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	3.58e-05	0.0113	CbGdCrCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.58e-05	0.000968	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—SMC1A—hematologic cancer	3.57e-05	0.000965	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	3.56e-05	0.000962	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.56e-05	0.000962	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	3.55e-05	0.000959	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	3.52e-05	0.000953	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—H3F3A—hematologic cancer	3.5e-05	0.000946	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	3.49e-05	0.000945	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.48e-05	0.000942	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	3.48e-05	0.000941	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.47e-05	0.000938	CbGpPWpGaD
Sparfloxacin—ABCB1—blood—hematologic cancer	3.47e-05	0.0262	CbGeAlD
Sparfloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	3.47e-05	0.0109	CbGdCrCtD
Sparfloxacin—ABCB1—Allograft Rejection—FASLG—hematologic cancer	3.44e-05	0.000931	CbGpPWpGaD
Sparfloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	3.37e-05	0.0106	CbGdCrCtD
Sparfloxacin—ABCB1—bone marrow—hematologic cancer	3.35e-05	0.0253	CbGeAlD
Sparfloxacin—ABCB1—Allograft Rejection—FAS—hematologic cancer	3.32e-05	0.000898	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	3.3e-05	0.000893	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	3.3e-05	0.000892	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	3.3e-05	0.000891	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.29e-05	0.000891	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK6—hematologic cancer	3.29e-05	0.000888	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	3.26e-05	0.000883	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.25e-05	0.000878	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.24e-05	0.000875	CbGpPWpGaD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	3.21e-05	0.0101	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	3.21e-05	0.0101	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	3.21e-05	0.0101	CbGdCrCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—hematologic cancer	3.16e-05	0.000854	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	3.13e-05	0.000845	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	3.12e-05	0.000845	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.11e-05	0.00084	CbGpPWpGaD
Sparfloxacin—ABCB1—lung—hematologic cancer	3.04e-05	0.023	CbGeAlD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	3.03e-05	0.000819	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	3.02e-05	0.000817	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.01e-05	0.000814	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—hematologic cancer	2.99e-05	0.000809	CbGpPWpGaD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	2.97e-05	0.00938	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	2.97e-05	0.00938	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	2.97e-05	0.00938	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	2.96e-05	0.000801	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—HSP90AA1—hematologic cancer	2.95e-05	0.000797	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	2.94e-05	0.000796	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	2.94e-05	0.000795	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	2.91e-05	0.000785	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	2.9e-05	0.000784	CbGpPWpGaD
Sparfloxacin—ABCB1—testis—hematologic cancer	2.87e-05	0.0217	CbGeAlD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.86e-05	0.000773	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	2.83e-05	0.000766	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.83e-05	0.000764	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND2—hematologic cancer	2.83e-05	0.000764	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.82e-05	0.000763	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD80—hematologic cancer	2.76e-05	0.000745	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.74e-05	0.00074	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.73e-05	0.000738	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—JUN—hematologic cancer	2.71e-05	0.000732	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.7e-05	0.000729	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	2.69e-05	0.000727	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.68e-05	0.000724	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	2.68e-05	0.000723	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.67e-05	0.000722	CbGpPWpGaD
Sparfloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	2.63e-05	0.0083	CbGdCrCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—hematologic cancer	2.62e-05	0.000708	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.62e-05	0.000708	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.61e-05	0.000705	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.6e-05	0.000704	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.6e-05	0.000703	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—MAPK8—hematologic cancer	2.56e-05	0.000693	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP8—hematologic cancer	2.56e-05	0.000693	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	2.55e-05	0.000691	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.55e-05	0.000689	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2B—hematologic cancer	2.53e-05	0.000685	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.53e-05	0.000684	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—EP300—hematologic cancer	2.5e-05	0.000676	CbGpPWpGaD
Sparfloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	2.48e-05	0.00784	CbGdCrCtD
Sparfloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	2.48e-05	0.00784	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.47e-05	0.000666	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.45e-05	0.000663	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	2.44e-05	0.000661	CbGpPWpGaD
Sparfloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	2.42e-05	0.00764	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.33e-05	0.00063	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	2.33e-05	0.000629	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.28e-05	0.000617	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.27e-05	0.000614	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.27e-05	0.000613	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.26e-05	0.000612	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	2.24e-05	0.000606	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	2.22e-05	0.0006	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BIRC5—hematologic cancer	2.19e-05	0.000591	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IFNG—hematologic cancer	2.18e-05	0.000589	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.17e-05	0.000588	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	2.17e-05	0.000588	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	2.16e-05	0.000585	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.14e-05	0.00058	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	2.12e-05	0.000573	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TERT—hematologic cancer	2.12e-05	0.000573	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.11e-05	0.000571	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.1e-05	0.000567	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	2.09e-05	0.000565	CbGpPWpGaD
Sparfloxacin—ABCB1—lymph node—hematologic cancer	2.08e-05	0.0157	CbGeAlD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.03e-05	0.00055	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	2.02e-05	0.000547	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	2.02e-05	0.000546	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK2—hematologic cancer	2.01e-05	0.000542	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	2.01e-05	0.000542	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	1.96e-05	0.000531	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	1.94e-05	0.000526	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	1.94e-05	0.000526	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL1B—hematologic cancer	1.94e-05	0.000525	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—hematologic cancer	1.94e-05	0.000524	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—hematologic cancer	1.94e-05	0.000523	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	1.93e-05	0.000521	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.93e-05	0.000521	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.91e-05	0.000515	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—ATM—hematologic cancer	1.9e-05	0.000515	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	1.9e-05	0.000514	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK4—hematologic cancer	1.9e-05	0.000512	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.86e-05	0.000504	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.86e-05	0.000503	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.86e-05	0.000503	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.86e-05	0.000503	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	1.84e-05	0.000498	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.81e-05	0.000489	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	1.79e-05	0.000483	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.78e-05	0.000482	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.75e-05	0.000473	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.7e-05	0.000459	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.67e-05	0.000453	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GMPS—hematologic cancer	1.66e-05	0.000448	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FTCD—hematologic cancer	1.66e-05	0.000448	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PHYH—hematologic cancer	1.66e-05	0.000448	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RB1—hematologic cancer	1.65e-05	0.000446	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	1.64e-05	0.000445	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.64e-05	0.000443	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	1.64e-05	0.000443	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.62e-05	0.000438	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.59e-05	0.00043	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.57e-05	0.000425	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.53e-05	0.000412	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SMPD3—hematologic cancer	1.52e-05	0.00041	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.51e-05	0.000408	CbGpPWpGaD
Sparfloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.48e-05	0.00468	CbGdCrCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.47e-05	0.000397	CbGpPWpGaD
Sparfloxacin—Rash—Gemcitabine—hematologic cancer	1.47e-05	8.31e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Gemcitabine—hematologic cancer	1.47e-05	8.3e-05	CcSEcCtD
Sparfloxacin—Hypersensitivity—Etoposide—hematologic cancer	1.46e-05	8.29e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.46e-05	0.000396	CbGpPWpGaD
Sparfloxacin—Tinnitus—Epirubicin—hematologic cancer	1.46e-05	8.28e-05	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—hematologic cancer	1.46e-05	8.26e-05	CcSEcCtD
Sparfloxacin—Headache—Gemcitabine—hematologic cancer	1.46e-05	8.26e-05	CcSEcCtD
Sparfloxacin—Nausea—Vincristine—hematologic cancer	1.46e-05	8.25e-05	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—hematologic cancer	1.46e-05	8.24e-05	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.45e-05	0.000393	CbGpPWpGaD
Sparfloxacin—Haemorrhage—Doxorubicin—hematologic cancer	1.45e-05	8.22e-05	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—hematologic cancer	1.45e-05	8.22e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	1.45e-05	0.000392	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.45e-05	0.000391	CbGpPWpGaD
Sparfloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.45e-05	0.00457	CbGdCrCtD
Sparfloxacin—Hypersensitivity—Prednisolone—hematologic cancer	1.44e-05	8.18e-05	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—hematologic cancer	1.44e-05	8.17e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.44e-05	0.00039	CbGpPWpGaD
Sparfloxacin—Pharyngitis—Doxorubicin—hematologic cancer	1.44e-05	8.15e-05	CcSEcCtD
Sparfloxacin—Dyspepsia—Dexamethasone—hematologic cancer	1.44e-05	8.15e-05	CcSEcCtD
Sparfloxacin—Dyspepsia—Betamethasone—hematologic cancer	1.44e-05	8.15e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.44e-05	0.000388	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.43e-05	0.000388	CbGpPWpGaD
Sparfloxacin—Urticaria—Triamcinolone—hematologic cancer	1.43e-05	8.11e-05	CcSEcCtD
Sparfloxacin—Oedema peripheral—Doxorubicin—hematologic cancer	1.43e-05	8.09e-05	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—hematologic cancer	1.43e-05	8.09e-05	CcSEcCtD
Sparfloxacin—Asthenia—Etoposide—hematologic cancer	1.43e-05	8.07e-05	CcSEcCtD
Sparfloxacin—Body temperature increased—Triamcinolone—hematologic cancer	1.43e-05	8.07e-05	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Prednisone—hematologic cancer	1.43e-05	8.07e-05	CcSEcCtD
Sparfloxacin—Decreased appetite—Dexamethasone—hematologic cancer	1.42e-05	8.05e-05	CcSEcCtD
Sparfloxacin—Decreased appetite—Betamethasone—hematologic cancer	1.42e-05	8.05e-05	CcSEcCtD
Sparfloxacin—Nausea—Mitoxantrone—hematologic cancer	1.42e-05	8.04e-05	CcSEcCtD
Sparfloxacin—Nausea—Irinotecan—hematologic cancer	1.42e-05	8.04e-05	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—hematologic cancer	1.41e-05	7.99e-05	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.41e-05	0.000381	CbGpPWpGaD
Sparfloxacin—Chills—Epirubicin—hematologic cancer	1.41e-05	7.97e-05	CcSEcCtD
Sparfloxacin—Pruritus—Etoposide—hematologic cancer	1.41e-05	7.96e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—hematologic cancer	1.41e-05	0.00038	CbGpPWpGaD
Sparfloxacin—Arrhythmia—Epirubicin—hematologic cancer	1.4e-05	7.93e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.4e-05	0.000379	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.4e-05	0.000379	CbGpPWpGaD
Sparfloxacin—Pain—Dexamethasone—hematologic cancer	1.4e-05	7.92e-05	CcSEcCtD
Sparfloxacin—Pain—Betamethasone—hematologic cancer	1.4e-05	7.92e-05	CcSEcCtD
Sparfloxacin—Tachycardia—Prednisone—hematologic cancer	1.39e-05	7.87e-05	CcSEcCtD
Sparfloxacin—Alopecia—Epirubicin—hematologic cancer	1.39e-05	7.85e-05	CcSEcCtD
Sparfloxacin—Nausea—Gemcitabine—hematologic cancer	1.38e-05	7.83e-05	CcSEcCtD
Sparfloxacin—Vomiting—Cisplatin—hematologic cancer	1.38e-05	7.81e-05	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Prednisone—hematologic cancer	1.38e-05	7.8e-05	CcSEcCtD
Sparfloxacin—Erythema multiforme—Doxorubicin—hematologic cancer	1.37e-05	7.77e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.37e-05	0.00037	CbGpPWpGaD
Sparfloxacin—Rash—Cisplatin—hematologic cancer	1.37e-05	7.75e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Cisplatin—hematologic cancer	1.37e-05	7.74e-05	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.36e-05	0.000368	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Etoposide—hematologic cancer	1.36e-05	7.7e-05	CcSEcCtD
Sparfloxacin—Anorexia—Prednisone—hematologic cancer	1.36e-05	7.69e-05	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—hematologic cancer	1.35e-05	7.66e-05	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—hematologic cancer	1.35e-05	7.66e-05	CcSEcCtD
Sparfloxacin—Feeling abnormal—Betamethasone—hematologic cancer	1.35e-05	7.63e-05	CcSEcCtD
Sparfloxacin—Feeling abnormal—Dexamethasone—hematologic cancer	1.35e-05	7.63e-05	CcSEcCtD
Sparfloxacin—Flatulence—Epirubicin—hematologic cancer	1.35e-05	7.62e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.34e-05	0.000363	CbGpPWpGaD
Sparfloxacin—Tension—Epirubicin—hematologic cancer	1.34e-05	7.59e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.34e-05	7.57e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.34e-05	7.57e-05	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—hematologic cancer	1.34e-05	7.57e-05	CcSEcCtD
Sparfloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	1.33e-05	7.52e-05	CcSEcCtD
Sparfloxacin—Nervousness—Epirubicin—hematologic cancer	1.33e-05	7.51e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.33e-05	0.000358	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—DCK—hematologic cancer	1.33e-05	0.000358	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ASNS—hematologic cancer	1.33e-05	0.000358	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.32e-05	0.000358	CbGpPWpGaD
Sparfloxacin—Back pain—Epirubicin—hematologic cancer	1.32e-05	7.48e-05	CcSEcCtD
Sparfloxacin—Malaise—Methotrexate—hematologic cancer	1.32e-05	7.45e-05	CcSEcCtD
Sparfloxacin—Dizziness—Etoposide—hematologic cancer	1.31e-05	7.44e-05	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—hematologic cancer	1.31e-05	7.42e-05	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—hematologic cancer	1.3e-05	7.37e-05	CcSEcCtD
Sparfloxacin—Urticaria—Dexamethasone—hematologic cancer	1.3e-05	7.36e-05	CcSEcCtD
Sparfloxacin—Urticaria—Betamethasone—hematologic cancer	1.3e-05	7.36e-05	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.3e-05	7.35e-05	CcSEcCtD
Sparfloxacin—Dizziness—Prednisolone—hematologic cancer	1.3e-05	7.34e-05	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—hematologic cancer	1.3e-05	7.34e-05	CcSEcCtD
Sparfloxacin—Asthenia—Triamcinolone—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Betamethasone—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Dexamethasone—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Sparfloxacin—Body temperature increased—Dexamethasone—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Sparfloxacin—Body temperature increased—Betamethasone—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.29e-05	0.000349	CbGpPWpGaD
Sparfloxacin—Nausea—Cisplatin—hematologic cancer	1.29e-05	7.3e-05	CcSEcCtD
Sparfloxacin—Insomnia—Prednisone—hematologic cancer	1.29e-05	7.3e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	1.28e-05	0.000347	CbGpPWpGaD
Sparfloxacin—Alopecia—Doxorubicin—hematologic cancer	1.28e-05	7.26e-05	CcSEcCtD
Sparfloxacin—Paraesthesia—Prednisone—hematologic cancer	1.28e-05	7.24e-05	CcSEcCtD
Sparfloxacin—Pruritus—Triamcinolone—hematologic cancer	1.28e-05	7.22e-05	CcSEcCtD
Sparfloxacin—Cough—Methotrexate—hematologic cancer	1.27e-05	7.21e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.27e-05	0.000343	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Epirubicin—hematologic cancer	1.27e-05	7.17e-05	CcSEcCtD
Sparfloxacin—Convulsion—Methotrexate—hematologic cancer	1.26e-05	7.16e-05	CcSEcCtD
Sparfloxacin—Vomiting—Etoposide—hematologic cancer	1.26e-05	7.16e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.26e-05	0.000342	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	1.26e-05	0.000341	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.26e-05	0.00034	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HDC—hematologic cancer	1.26e-05	0.00034	CbGpPWpGaD
Sparfloxacin—Agitation—Epirubicin—hematologic cancer	1.25e-05	7.1e-05	CcSEcCtD
Sparfloxacin—Dyspepsia—Prednisone—hematologic cancer	1.25e-05	7.1e-05	CcSEcCtD
Sparfloxacin—Rash—Etoposide—hematologic cancer	1.25e-05	7.1e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Etoposide—hematologic cancer	1.25e-05	7.09e-05	CcSEcCtD
Sparfloxacin—Headache—Etoposide—hematologic cancer	1.25e-05	7.05e-05	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—hematologic cancer	1.25e-05	7.05e-05	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—hematologic cancer	1.24e-05	7.03e-05	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—hematologic cancer	1.24e-05	7.03e-05	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—hematologic cancer	1.24e-05	7.03e-05	CcSEcCtD
Sparfloxacin—Tension—Doxorubicin—hematologic cancer	1.24e-05	7.02e-05	CcSEcCtD
Sparfloxacin—Decreased appetite—Prednisone—hematologic cancer	1.24e-05	7.01e-05	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—hematologic cancer	1.24e-05	7e-05	CcSEcCtD
Sparfloxacin—Rash—Prednisolone—hematologic cancer	1.24e-05	7e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Prednisolone—hematologic cancer	1.24e-05	6.99e-05	CcSEcCtD
Sparfloxacin—Malaise—Epirubicin—hematologic cancer	1.23e-05	6.97e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.23e-05	0.000333	CbGpPWpGaD
Sparfloxacin—Headache—Prednisolone—hematologic cancer	1.23e-05	6.95e-05	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—hematologic cancer	1.23e-05	6.95e-05	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—hematologic cancer	1.23e-05	6.95e-05	CcSEcCtD
Sparfloxacin—Vertigo—Epirubicin—hematologic cancer	1.23e-05	6.94e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—hematologic cancer	1.22e-05	0.000331	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.22e-05	0.000331	CbGpPWpGaD
Sparfloxacin—Back pain—Doxorubicin—hematologic cancer	1.22e-05	6.92e-05	CcSEcCtD
Sparfloxacin—Constipation—Prednisone—hematologic cancer	1.22e-05	6.9e-05	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.21e-05	0.000328	CbGpPWpGaD
Sparfloxacin—Palpitations—Epirubicin—hematologic cancer	1.21e-05	6.83e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.2e-05	0.000325	CbGpPWpGaD
Sparfloxacin—Confusional state—Methotrexate—hematologic cancer	1.2e-05	6.8e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.2e-05	0.000324	CbGpPWpGaD
Sparfloxacin—Dizziness—Triamcinolone—hematologic cancer	1.19e-05	6.75e-05	CcSEcCtD
Sparfloxacin—Cough—Epirubicin—hematologic cancer	1.19e-05	6.75e-05	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	1.19e-05	6.74e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	1.18e-05	0.00032	CbGpPWpGaD
Sparfloxacin—Convulsion—Epirubicin—hematologic cancer	1.18e-05	6.7e-05	CcSEcCtD
Sparfloxacin—Nausea—Etoposide—hematologic cancer	1.18e-05	6.68e-05	CcSEcCtD
Sparfloxacin—Hypertension—Epirubicin—hematologic cancer	1.18e-05	6.67e-05	CcSEcCtD
Sparfloxacin—Feeling abnormal—Prednisone—hematologic cancer	1.17e-05	6.65e-05	CcSEcCtD
Sparfloxacin—Asthenia—Dexamethasone—hematologic cancer	1.17e-05	6.65e-05	CcSEcCtD
Sparfloxacin—Asthenia—Betamethasone—hematologic cancer	1.17e-05	6.65e-05	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.17e-05	6.64e-05	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	1.17e-05	6.6e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	1.17e-05	6.6e-05	CcSEcCtD
Sparfloxacin—Nausea—Prednisolone—hematologic cancer	1.16e-05	6.59e-05	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—hematologic cancer	1.16e-05	6.58e-05	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—hematologic cancer	1.16e-05	6.58e-05	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—hematologic cancer	1.16e-05	6.58e-05	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—hematologic cancer	1.16e-05	6.57e-05	CcSEcCtD
Sparfloxacin—Anxiety—Epirubicin—hematologic cancer	1.16e-05	6.56e-05	CcSEcCtD
Sparfloxacin—Pruritus—Dexamethasone—hematologic cancer	1.16e-05	6.55e-05	CcSEcCtD
Sparfloxacin—Pruritus—Betamethasone—hematologic cancer	1.16e-05	6.55e-05	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	1.15e-05	6.52e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—CDA—hematologic cancer	1.15e-05	0.000311	CbGpPWpGaD
Sparfloxacin—Discomfort—Epirubicin—hematologic cancer	1.15e-05	6.5e-05	CcSEcCtD
Sparfloxacin—Vomiting—Triamcinolone—hematologic cancer	1.15e-05	6.49e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.14e-05	0.000309	CbGpPWpGaD
Sparfloxacin—Malaise—Doxorubicin—hematologic cancer	1.14e-05	6.45e-05	CcSEcCtD
Sparfloxacin—Rash—Triamcinolone—hematologic cancer	1.14e-05	6.44e-05	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—hematologic cancer	1.14e-05	6.44e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Triamcinolone—hematologic cancer	1.14e-05	6.43e-05	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—hematologic cancer	1.14e-05	6.43e-05	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—hematologic cancer	1.14e-05	6.43e-05	CcSEcCtD
Sparfloxacin—Urticaria—Prednisone—hematologic cancer	1.13e-05	6.41e-05	CcSEcCtD
Sparfloxacin—Headache—Triamcinolone—hematologic cancer	1.13e-05	6.39e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.13e-05	0.000305	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—EP300—hematologic cancer	1.13e-05	0.000305	CbGpPWpGaD
Sparfloxacin—Body temperature increased—Prednisone—hematologic cancer	1.13e-05	6.38e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Prednisone—hematologic cancer	1.13e-05	6.38e-05	CcSEcCtD
Sparfloxacin—Confusional state—Epirubicin—hematologic cancer	1.12e-05	6.36e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Betamethasone—hematologic cancer	1.12e-05	6.34e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Dexamethasone—hematologic cancer	1.12e-05	6.34e-05	CcSEcCtD
Sparfloxacin—Palpitations—Doxorubicin—hematologic cancer	1.12e-05	6.32e-05	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	1.11e-05	6.31e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—PC—hematologic cancer	1.11e-05	0.000299	CbGpPWpGaD
Sparfloxacin—Cough—Doxorubicin—hematologic cancer	1.1e-05	6.24e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	1.1e-05	0.000297	CbGpPWpGaD
Sparfloxacin—Convulsion—Doxorubicin—hematologic cancer	1.09e-05	6.2e-05	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	1.09e-05	6.18e-05	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—hematologic cancer	1.09e-05	6.17e-05	CcSEcCtD
Sparfloxacin—Tachycardia—Epirubicin—hematologic cancer	1.09e-05	6.16e-05	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.09e-05	6.14e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.08e-05	0.000293	CbGpPWpGaD
Sparfloxacin—Dizziness—Dexamethasone—hematologic cancer	1.08e-05	6.12e-05	CcSEcCtD
Sparfloxacin—Dizziness—Betamethasone—hematologic cancer	1.08e-05	6.12e-05	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	1.08e-05	6.1e-05	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—hematologic cancer	1.08e-05	6.1e-05	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—hematologic cancer	1.08e-05	6.09e-05	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—hematologic cancer	1.08e-05	6.09e-05	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—hematologic cancer	1.08e-05	6.09e-05	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—hematologic cancer	1.07e-05	6.07e-05	CcSEcCtD
Sparfloxacin—Nausea—Triamcinolone—hematologic cancer	1.07e-05	6.06e-05	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—hematologic cancer	1.07e-05	6.05e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.07e-05	0.000289	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.07e-05	0.000289	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GBA—hematologic cancer	1.07e-05	0.000289	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.07e-05	0.000289	CbGpPWpGaD
Sparfloxacin—Discomfort—Doxorubicin—hematologic cancer	1.06e-05	6.02e-05	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.06e-05	0.000287	CbGpPWpGaD
Sparfloxacin—Anorexia—Epirubicin—hematologic cancer	1.06e-05	6.01e-05	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—hematologic cancer	1.06e-05	6.01e-05	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—hematologic cancer	1.06e-05	5.99e-05	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—hematologic cancer	1.05e-05	5.96e-05	CcSEcCtD
Sparfloxacin—Hypersensitivity—Prednisone—hematologic cancer	1.05e-05	5.94e-05	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—hematologic cancer	1.05e-05	5.93e-05	CcSEcCtD
Sparfloxacin—Vomiting—Betamethasone—hematologic cancer	1.04e-05	5.89e-05	CcSEcCtD
Sparfloxacin—Vomiting—Dexamethasone—hematologic cancer	1.04e-05	5.89e-05	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—hematologic cancer	1.04e-05	5.89e-05	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—hematologic cancer	1.04e-05	5.86e-05	CcSEcCtD
Sparfloxacin—Rash—Dexamethasone—hematologic cancer	1.03e-05	5.84e-05	CcSEcCtD
Sparfloxacin—Rash—Betamethasone—hematologic cancer	1.03e-05	5.84e-05	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.03e-05	5.84e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Dexamethasone—hematologic cancer	1.03e-05	5.83e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Betamethasone—hematologic cancer	1.03e-05	5.83e-05	CcSEcCtD
Sparfloxacin—Headache—Dexamethasone—hematologic cancer	1.03e-05	5.8e-05	CcSEcCtD
Sparfloxacin—Headache—Betamethasone—hematologic cancer	1.03e-05	5.8e-05	CcSEcCtD
Sparfloxacin—Asthenia—Prednisone—hematologic cancer	1.02e-05	5.79e-05	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—hematologic cancer	1.02e-05	5.76e-05	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.02e-05	5.75e-05	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.01e-05	5.72e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	1.01e-05	0.000273	CbGpPWpGaD
Sparfloxacin—Pruritus—Prednisone—hematologic cancer	1.01e-05	5.71e-05	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—hematologic cancer	1.01e-05	5.71e-05	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—hematologic cancer	1.01e-05	5.7e-05	CcSEcCtD
Sparfloxacin—Paraesthesia—Epirubicin—hematologic cancer	1e-05	5.66e-05	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	9.97e-06	5.64e-05	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	9.95e-06	0.000269	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Epirubicin—hematologic cancer	9.94e-06	5.62e-05	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—hematologic cancer	9.91e-06	5.61e-05	CcSEcCtD
Sparfloxacin—Anorexia—Doxorubicin—hematologic cancer	9.83e-06	5.56e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—MYC—hematologic cancer	9.82e-06	0.000265	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Methotrexate—hematologic cancer	9.81e-06	5.56e-05	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—hematologic cancer	9.81e-06	5.55e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—MTAP—hematologic cancer	9.77e-06	0.000264	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	9.76e-06	0.000264	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Prednisone—hematologic cancer	9.75e-06	5.52e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	9.74e-06	5.51e-05	CcSEcCtD
Sparfloxacin—Nausea—Dexamethasone—hematologic cancer	9.72e-06	5.5e-05	CcSEcCtD
Sparfloxacin—Nausea—Betamethasone—hematologic cancer	9.72e-06	5.5e-05	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—hematologic cancer	9.69e-06	5.48e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	9.57e-06	0.000259	CbGpPWpGaD
Sparfloxacin—Pain—Epirubicin—hematologic cancer	9.53e-06	5.39e-05	CcSEcCtD
Sparfloxacin—Constipation—Epirubicin—hematologic cancer	9.53e-06	5.39e-05	CcSEcCtD
Sparfloxacin—Urticaria—Methotrexate—hematologic cancer	9.46e-06	5.36e-05	CcSEcCtD
Sparfloxacin—Dizziness—Prednisone—hematologic cancer	9.42e-06	5.33e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—hematologic cancer	9.41e-06	5.33e-05	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—hematologic cancer	9.41e-06	5.33e-05	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.4e-06	5.32e-05	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—hematologic cancer	9.33e-06	5.28e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	9.31e-06	0.000252	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	9.29e-06	0.000251	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Doxorubicin—hematologic cancer	9.26e-06	5.24e-05	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—hematologic cancer	9.19e-06	5.2e-05	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—hematologic cancer	9.18e-06	5.2e-05	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—hematologic cancer	9.17e-06	5.19e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	9.11e-06	5.16e-05	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—hematologic cancer	9.08e-06	5.14e-05	CcSEcCtD
Sparfloxacin—Vomiting—Prednisone—hematologic cancer	9.06e-06	5.13e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	9.01e-06	0.000244	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	8.99e-06	0.000243	CbGpPWpGaD
Sparfloxacin—Rash—Prednisone—hematologic cancer	8.99e-06	5.09e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Prednisone—hematologic cancer	8.98e-06	5.08e-05	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—hematologic cancer	8.96e-06	5.07e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.96e-06	0.000242	CbGpPWpGaD
Sparfloxacin—Headache—Prednisone—hematologic cancer	8.93e-06	5.05e-05	CcSEcCtD
Sparfloxacin—Urticaria—Epirubicin—hematologic cancer	8.85e-06	5.01e-05	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—hematologic cancer	8.82e-06	4.99e-05	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—hematologic cancer	8.82e-06	4.99e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—hematologic cancer	8.81e-06	4.99e-05	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—hematologic cancer	8.81e-06	4.99e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	8.79e-06	0.000238	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Methotrexate—hematologic cancer	8.77e-06	4.97e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—FHL2—hematologic cancer	8.71e-06	0.000235	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	8.57e-06	0.000232	CbGpPWpGaD
Sparfloxacin—Asthenia—Methotrexate—hematologic cancer	8.54e-06	4.84e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—AGRN—hematologic cancer	8.54e-06	0.000231	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	8.5e-06	4.81e-05	CcSEcCtD
Sparfloxacin—Nausea—Prednisone—hematologic cancer	8.46e-06	4.79e-05	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.43e-06	4.77e-05	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—hematologic cancer	8.43e-06	4.77e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.33e-06	0.000225	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Epirubicin—hematologic cancer	8.21e-06	4.65e-05	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—hematologic cancer	8.19e-06	4.64e-05	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—hematologic cancer	8.15e-06	4.61e-05	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—hematologic cancer	8.15e-06	4.61e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—hematologic cancer	8.15e-06	4.61e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	8.12e-06	0.000219	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMMR—hematologic cancer	8.09e-06	0.000219	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—IDH2—hematologic cancer	8.09e-06	0.000219	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	8.06e-06	0.000218	CbGpPWpGaD
Sparfloxacin—Asthenia—Epirubicin—hematologic cancer	8e-06	4.53e-05	CcSEcCtD
Sparfloxacin—Pruritus—Epirubicin—hematologic cancer	7.89e-06	4.46e-05	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—hematologic cancer	7.88e-06	4.46e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.68e-06	0.000208	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Epirubicin—hematologic cancer	7.63e-06	4.32e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—ARNTL—hematologic cancer	7.61e-06	0.000206	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	7.6e-06	4.3e-05	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—hematologic cancer	7.57e-06	4.29e-05	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—hematologic cancer	7.51e-06	4.25e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—hematologic cancer	7.5e-06	4.25e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.47e-06	0.000202	CbGpPWpGaD
Sparfloxacin—Headache—Methotrexate—hematologic cancer	7.46e-06	4.22e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.45e-06	0.000201	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACP5—hematologic cancer	7.4e-06	0.0002	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CA9—hematologic cancer	7.4e-06	0.0002	CbGpPWpGaD
Sparfloxacin—Asthenia—Doxorubicin—hematologic cancer	7.4e-06	4.19e-05	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—hematologic cancer	7.37e-06	4.17e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—NCOR2—hematologic cancer	7.31e-06	0.000198	CbGpPWpGaD
Sparfloxacin—Pruritus—Doxorubicin—hematologic cancer	7.3e-06	4.13e-05	CcSEcCtD
Sparfloxacin—Vomiting—Epirubicin—hematologic cancer	7.09e-06	4.01e-05	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—hematologic cancer	7.07e-06	4e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—hematologic cancer	7.06e-06	3.99e-05	CcSEcCtD
Sparfloxacin—Rash—Epirubicin—hematologic cancer	7.03e-06	3.98e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—hematologic cancer	7.02e-06	3.97e-05	CcSEcCtD
Sparfloxacin—Headache—Epirubicin—hematologic cancer	6.98e-06	3.95e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—IDH1—hematologic cancer	6.96e-06	0.000188	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.96e-06	0.000188	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.9e-06	0.000187	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TXN—hematologic cancer	6.88e-06	0.000186	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTO1—hematologic cancer	6.88e-06	0.000186	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCC3—hematologic cancer	6.88e-06	0.000186	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—hematologic cancer	6.82e-06	3.86e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—SPHK1—hematologic cancer	6.74e-06	0.000182	CbGpPWpGaD
Sparfloxacin—Nausea—Epirubicin—hematologic cancer	6.62e-06	3.75e-05	CcSEcCtD
Sparfloxacin—Vomiting—Doxorubicin—hematologic cancer	6.56e-06	3.71e-05	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—hematologic cancer	6.5e-06	3.68e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—hematologic cancer	6.5e-06	3.68e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.47e-06	0.000175	CbGpPWpGaD
Sparfloxacin—Headache—Doxorubicin—hematologic cancer	6.46e-06	3.66e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.34e-06	0.000171	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.29e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CRABP1—hematologic cancer	6.29e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALOX5—hematologic cancer	6.13e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.13e-06	0.000166	CbGpPWpGaD
Sparfloxacin—Nausea—Doxorubicin—hematologic cancer	6.13e-06	3.47e-05	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—NUP98—hematologic cancer	5.94e-06	0.000161	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ADCY7—hematologic cancer	5.77e-06	0.000156	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA3—hematologic cancer	5.77e-06	0.000156	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NUP214—hematologic cancer	5.73e-06	0.000155	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG2—hematologic cancer	5.61e-06	0.000152	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTR—hematologic cancer	5.61e-06	0.000152	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ENO2—hematologic cancer	5.5e-06	0.000149	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTT1—hematologic cancer	5.34e-06	0.000144	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SDC1—hematologic cancer	5.22e-06	0.000141	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.18e-06	0.00014	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5e-06	0.000135	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.68e-06	0.000126	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NQO1—hematologic cancer	4.44e-06	0.00012	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CD44—hematologic cancer	4.44e-06	0.00012	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYCS—hematologic cancer	4.2e-06	0.000113	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.17e-06	0.000113	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—hematologic cancer	3.7e-06	0.0001	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOR1—hematologic cancer	3.4e-06	9.19e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—hematologic cancer	3.4e-06	9.19e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTHFR—hematologic cancer	3e-06	8.12e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.52e-06	6.82e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CREBBP—hematologic cancer	2.34e-06	6.33e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.22e-06	6e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—hematologic cancer	2.19e-06	5.92e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.1e-06	5.66e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.93e-06	5.23e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—hematologic cancer	1.67e-06	4.52e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—EP300—hematologic cancer	1.59e-06	4.31e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.18e-06	3.19e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—hematologic cancer	9.63e-07	2.6e-05	CbGpPWpGaD
